Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts. On July…
Tag: Pharmaceuticals
Jazz Pharmaceuticals (JAZZ) Highlights Growth at Goldman Sachs Healthcare Conference
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) is one of the 7 most undervalued pot stocks to buy according to analysts. On June…
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright have reiterated…
Barclays Upgrades Ionis Pharmaceuticals (IONS) Stock, Raises PT
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Barclays upgraded…
Why Skyrocketed Recursion Pharmaceuticals, Inc. (RXRX) Today
We recently published a list of These 10 Stocks Are On Fire Right Now. In this article, we are going…
Biodexa Pharmaceuticals sees cash runway into 1Q26
As of May 29, 2025, the Company had access to the following cash resources: Cash at bank $5.7M; Cash in…
Truist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price Target
On Tuesday, May 27, an analyst from Truist Securities initiated coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a Buy…
ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) has unveiled promising early results from its Phase 1b trial of ORIC-944, a novel PRC2 inhibitor,…
Accretion Pharmaceuticals IPO listing today. Check GMP ahead of debut
Accretion Pharmaceuticals, a Gujarat-based pharma manufacturer, concluded its Rs 29.75 crore SME IPO on May 16. The issue, priced between…
Acadia Pharmaceuticals price target raised to $19 from $17 at Oppenheimer
Oppenheimer raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $19 from $17 and keeps a Perform rating on…